The end of the COVID-19 pandemic will not be linear, homogeneous or simultaneous, enabling the virus to become endemic. As outbreaks become increasingly localized, companies and individuals around the world will face short-term uncertainty surrounding the resumption of activity and travel as they navigate disjointed policies and requirements. The developing world, meanwhile, will likely face long-term disadvantages of endemic disease and waning international interest. With vaccination campaigns in the United States and Europe now in full swing, the developed world will start to hit the ceiling of vaccine hesitancy and/or political pushback by the end of the year. And in the developing world, bottlenecks holding up vaccine distribution and the resumption of international travel will continue to create pockets for transmission, keeping low levels of COVID-19 in those populations with the potential for localized and possibly seasonal outbreaks. ...
